An overview of tuberculosis: infection, immune response and preventive strategies Flashcards

1
Q

Describe the properties of Mycobacterium tuberculosis

A

*acid-fast bacilli (rods) - The high lipid content (mycolic acids) of their cell wall makes mycobacteria acid-fast.
*gram-positive bacterium
*grows slowly
* obligate aerobe - explain the causing disease in highly oxygenated tissues such as the upper lobe of the lung and the kidney.
*Cord factor (trehalose dimycolate) is correlated with virulence of the organism.
*relatively resistant to acids and alkalis. resistant to dehydration and therefore survives in dried expectorated sputum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the transmission of Mycobacterium tuberculosis

A
  • transmitted from person to person by respiratory aerosols produced by coughing
  • Risk factors: household sharing and crowding
  • The portal of entry is the respiratory tract
    and the initial site of infection is the lung.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the pathogenesis of Mycobacterium tuberculosis

A

Mycobacterium tuberculosis produces no exotoxins and does not contain endotoxin in its cell wall. The organism preferentially infects macrophages and other reticuloendothelial cells.

Mycobacterium tuberculosis survives and multiplies within a phagosome. The organism produces a protein called “exported repetitive protein” that prevents the phagosome from fusing with the lysosome, thereby allowing the organism to escape the degradative enzymes in the lysosome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the outcomes of primary and secondary TB?

A

primary tuberculosis which typically results in a Ghon focus in the lower lung. Primary tuberculosis can heal by fibrosis, can lead to progressive lung disease, can cause bacteremia and miliary tuberculosis, or cause hematogenous dissemination resulting in no immediate disease but with the risk of reactivation in later life.

secondary tuberculosis with a cavity in the upper lobes. This can cause disease directly or result in reactivation disease in later life with central nervous system lesions, vertebral osteomyelitis (Pott’s disease), or involvement of other organs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Where do LTBI bacteria reside?

A
  • There is no clearcut evidence as to where LTBI reside
  • It is thought that LTBI may consist of multiple bacillary populations, those growing rapidly and those metabolically inactive
  • Conventional view is that the bacteria reside in lung macrophages
  • Alternative view: extracellular localisation within lung tissue, similar to ‘persister’ bacilli during drug treatment
  • However, some evidence suggests bronchial lymph nodes and tonsils
  • Recent studies detected MTB in autopsies from spleen, liver and kidneys
  • MTB DNA was also detected in adipose tissues surrounding stomach, heart, kidneys and skin
  • Thus LTBI may represent a spectrum of asymptomatic conditions with varying risk of reactivation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Risk factors for reactivation of TB?

A
  • Malnutrition
  • Poverty
  • Immunosuppression
  • Diabetes
  • Old age
  • Poor health
  • HIV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

The difference between latent TB infection and active TB Disease?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Other than the lungs what are other sites infection?

A

-larynx
-lymph nodes
-kidneys
-brain & spine
-bones & joints

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the Ghon focus

A

Initial infection with Mycobacterium tuberculosis in an immunocompetent individual usually occurs in an upper region of lower lobe of the lung producing a lesion called a Ghon focus

Granulomatous involvement of peribronchial and/or hilar lymph nodes is frequent in primary tuberculosis due to lymphangitic spread from the Ghon focus.

The early Ghon focus together with the lymph node lesion constitute the Ghon complex

These lesions undergo healing and over time usually evolve to fibro- calcific nodules.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

When does miliary TB occur?

A

Miliary tuberculosis, as seen here, typically occurs when resistance to mycobacterial
infection is poor and often in children as consequence of primary disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what does Pulmonary Tuberculosis look like on a CT scan?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does TB look like in the brain and meninges?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name the disease for:
1. TB diseases of the spine
2.Lymph node TB

A
  1. Potts disease
  2. Scrofula
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Immuno-Pathogenesis of MTB infection

A
  1. Inhalation
  2. Alveolar macrophages
  3. Lymph nodes
  4. Haematogenous spread to other parts of lung via lymphatics and capillaries
  5. A brief acute inflammatory response -
    neutrophils, cytokine storms
    macrophage recruitment and activation
  6. recruitment of CD4, CD8 and NK cells - production of IFN-y
  7. Down regulation of acute inflammation → chronic inflammation
  8. Formation of granuloma - immune containment
  9. Caseation
  10. Liquefaction, cavitation and release
  11. Transmission
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

explain how the Immune response in TB is a ‘double-edged sward’

A

Good
➢Innate immunity: alveolar macrophages kill ingested bacilli
➢Th1 adoptive immune response: CD8 and CD4 T cells, IFN-gamma: essential for controlling infection

Bad
Excessive immune response leads to overproduction of TNF-alpha and healthy
tissue damage and fibrosis (immunopathology of TB).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Immune response to TB determines outcome
of infection

A

Innate immune response:
➢ Macrophages
➢ Granuloma formation

Acquired immune response:
➢Develops typically from 2 weeks onwards
➢Requires presentation of mycobacterial
antigen-peptides to T cells
➢Dendritic cells are the most important
antigen-presenting cells (other being
macrophages and memory B cells)

17
Q

Describe Killing by phagocytosis and phago-lysosome fusion

A

Most efficient phagocyte for killing MTB, but also shelter for bacteria (because
MTB evolved strategies for avoiding intracellular killi

18
Q

What is the purpose and downside of Tuberculous Granuloma

A

Containment of infection but also leads to tissue damage

19
Q

Describe the Granuloma composition

A

An immunological granuloma typically has a core of epithelioid cells and macrophages, sometimes with giant cells. In some diseases, such as tuberculosis, this central area may
have a zone of necrosis, with complete destruction of all cellular architecture.

The macrophage/epithelioid core is surrounded by a cuff of lymphocytes, and there may also be considerable fibrosis
(deposition of collagen fibers) caused by proliferation of fibroblasts and increased collagen synthesis.

TNF and the related cytokine, lymphotoxin-a, are both essential for the formation of granulomas during mycobacterial infections

the Liquefaction of granuloma and cavitation lead to transmission

20
Q

Describe the Liquefaction of granuloma and cavitation lead to transmission

A
21
Q

Functions of the different T cell types in TB?

A
  • CD8+ cells: Kill MTB infected cells
  • CD4+ cells:
    – TH1: Activate macrophages by
    production of IFN-gamma, to aggressively ingest
    antigen and to kill ingested MTB.
    – TH2: Stimulate B cells (via production of cytokines such as IL-4, IL-13 and also via cell-cell contact) to differentiate into antibody-producing plasma cells
22
Q

Tests for TB and LTBI

A

➢Chest x-ray
➢Sputum cultures
➢Tuberculin skin test
➢Interferon (IFN)-gamma blood test. This type of test looks for
an immune response to proteins produced by M. tuberculosis.
➢Rarely, biopsy of the affected tissue (typically lungs, pleura, or lymph nodes)
➢New: GeneXpert
➢Mantoux test: Cell-mediated delayed type hypersensitivity response (Type IV)
Detects exposure to MTB, does not diagnose TB

23
Q

How do we use sputum cultures to test for MTB?

A

*Ziehl-Neelsen (ZN) stain
microscopy
Acid Fast

*auramine stain
- fluorescence microscopy.

24
Q

What are the Drugs for Tuberculosis

A
  • 1943 - Streptomycin
  • 1952 - Isoniazid
  • 1954 - Pyrazinamide
  • 1955 - Cycloserine
  • 1962 - Ethambutol
  • 1963 - Rifampin
25
Q

TB Drug treatment

A

➢protracted: 6-9 months
➢Usually 4-6 drugs
➢Most drugs act only on dividing bacilli
➢High relapse rate due to poor compliance
➢Increase in MDR-TB
➢DOTS (directly observed treatment short course)

26
Q

Describe Strains of M. tuberculosis resistant to multiple drugs (MDR strains)/MDR-TB

A

Resistance to both isoniazid and rifampicin
* Loss of 2 most powerful TB drugs
* 190,000 deaths in 2015 (14% of all cases)

Treatment:
*The treatment of MDR organisms usually
involves the use of four or five drugs, including ciprofloxacin, amikacin, ethionamide, and cycloserine.
*Less effective
*Longer duration (6 mo vs 2 years)
*More side-effects
*Much more expensive
*One approach to the problem of noncompliance is directly observed therapy (DOT), in which health care workers observe the patient taking the medication
*New drugs such as bedaquiline and delamanid offer hope

27
Q

Vaccination for TB

A

BCG
- Attenuated M. bovis called Bacillus Calmette-Guerin
- The most heavily used vaccine in medical history
- Given usually to infants or in early childhood
- Protects against disseminated primary infection
- Ineffective against reactivation adult TB

28
Q

Why does BCG vaccination fail?

A
  • Protection ranges from 80% to zero in
    different parts of the world
  • Environmental influences
  • Vaccination is given to infants but
    protection only lasts about 15 years.
  • strong protection against childhood TB
    -little against the adult infectious form
  • Boost with BCG does not work
29
Q

What are the difficulties in testing TB vaccines in
animal models

A
30
Q

What are the types of new candidates for vaccines?

A
  • Attenuated M. tuberculosis
  • Recombinant BCG
  • Recombinant virus vector expressing MTB
    antigens
  • Protein subunit plus adjuvant
  • DNA
    Prime-boost strategy: Prime with BCG, then
    boost with a new vaccine
    There are no defined correlates of protection in TB